76 related articles for article (PubMed ID: 22534780)
1. Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
Mukherjee B; Delancey JO; Raskin L; Everett J; Jeter J; Begg CB; Orlow I; Berwick M; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Culver HA; Rosso S; Zanetti R; Kanetsky PA; From L; Gruber SB;
J Natl Cancer Inst; 2012 Jun; 104(12):953-6. PubMed ID: 22534780
[TBL] [Abstract][Full Text] [Related]
2. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model.
Pandharipande PV; Jeon A; Heberle CR; Dowling EC; Kong CY; Chung DC; Brugge WR; Hur C
EBioMedicine; 2015 Dec; 2(12):1980-6. PubMed ID: 26844277
[TBL] [Abstract][Full Text] [Related]
3. MELPREDICT: a logistic regression model to estimate CDKN2A carrier probability.
Niendorf KB; Goggins W; Yang G; Tsai KY; Shennan M; Bell DW; Sober AJ; Hogg D; Tsao H
J Med Genet; 2006 Jun; 43(6):501-6. PubMed ID: 16169933
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
Leof ER; Zhu X; Rabe KG; McCormick JB; Petersen GM; Radecki Breitkopf C
Genet Med; 2019 Nov; 21(11):2468-2477. PubMed ID: 30992552
[TBL] [Abstract][Full Text] [Related]
5. Empowering Family Glaucoma Risk Communication Using QR-Code-Mediated Online Intervention.
Hallaj S; Shah SJ; Cehelyk EK; Hock LE; Lee D; Razeghinejad R; Myers JS; Frasso R; Kolomeyer NN
Ophthalmol Glaucoma; 2024; 7(2):190-196. PubMed ID: 37838087
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives After Community-Based and Hospital-Based Approaches.
Nitikarun P; Kongsap P
Clin Ophthalmol; 2024; 18():1563-1573. PubMed ID: 38832077
[TBL] [Abstract][Full Text] [Related]
7. Risk of schizophrenia in relatives of individuals affected by schizophrenia: A meta-analysis.
LE L; R K; B M; Mj G
Psychiatry Res; 2020 Feb; 286():112852. PubMed ID: 32065982
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Direct Health Education on the Uptake of Screening by First Degree Relatives of Glaucoma Patients in Nigeria.
Ogunleye O; Olawoye O; Sarimiye T; Bekibele C; Ashaye A
J Glaucoma; 2021 May; 30(5):395-401. PubMed ID: 33394849
[TBL] [Abstract][Full Text] [Related]
9. CDKN2a mutation-negative melanoma families have increased risk exclusively for skin cancers but not for other malignancies.
Helgadottir H; Höiom V; Tuominen R; Jönsson G; Månsson-Brahme E; Olsson H; Hansson J
Int J Cancer; 2015 Nov; 137(9):2220-6. PubMed ID: 25943250
[TBL] [Abstract][Full Text] [Related]
10. Understanding familial risk of pancreatic ductal adenocarcinoma.
Paranal RM; Wood LD; Klein AP; Roberts NJ
Fam Cancer; 2024 Apr; ():. PubMed ID: 38609521
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment.
Kuras M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762707
[TBL] [Abstract][Full Text] [Related]
12. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities.
Farr KP; Moses D; Haghighi KS; Phillips PA; Hillenbrand CM; Chua BH
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626142
[TBL] [Abstract][Full Text] [Related]
13. Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of
Pauley K; Khan A; Kohlmann W; Jeter J
Front Oncol; 2022; 12():837057. PubMed ID: 35372037
[TBL] [Abstract][Full Text] [Related]
14. Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives.
Antwi SO; Rabe KG; Bamlet WR; Meyer M; Chandra S; Fagan SE; Hu C; Couch FJ; McWilliams RR; Oberg AL; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):372-381. PubMed ID: 34782396
[TBL] [Abstract][Full Text] [Related]
15. The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer.
Kimura H; Klein AP; Hruban RH; Roberts NJ
Pancreas; 2021 Sep; 50(8):1123-1130. PubMed ID: 34714275
[TBL] [Abstract][Full Text] [Related]
16. Familial Melanoma and Susceptibility Genes: A Review of the Most Common Clinical and Dermoscopic Phenotypic Aspect, Associated Malignancies and Practical Tips for Management.
Zocchi L; Lontano A; Merli M; Dika E; Nagore E; Quaglino P; Puig S; Ribero S
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442055
[TBL] [Abstract][Full Text] [Related]
17. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
Thompson ED; Roberts NJ; Wood LD; Eshleman JR; Goggins MG; Kern SE; Klein AP; Hruban RH
Mod Pathol; 2020 Dec; 33(12):2544-2563. PubMed ID: 32704031
[TBL] [Abstract][Full Text] [Related]
18. Early detection of pancreatic cancer.
Pereira SP; Oldfield L; Ney A; Hart PA; Keane MG; Pandol SJ; Li D; Greenhalf W; Jeon CY; Koay EJ; Almario CV; Halloran C; Lennon AM; Costello E
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):698-710. PubMed ID: 32135127
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of
Ciceri S; Gamba B; Corbetta P; Mondini P; Terenziani M; Catania S; Nantron M; Bianchi M; D'Angelo P; Torri F; Macciardi F; Collini P; Di Martino M; Melchionda F; Di Cataldo A; Spreafico F; Radice P; Perotti D;
Oncotarget; 2018 Sep; 9(75):34079-34089. PubMed ID: 30344923
[TBL] [Abstract][Full Text] [Related]
20. Inherited pancreatic cancer.
Chen F; Roberts NJ; Klein AP
Chin Clin Oncol; 2017 Dec; 6(6):58. PubMed ID: 29307198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
